BERIL-1: Biomarker results from targeted sequencing of circulating tumor DNA (ctDNA) and archival tissue in a randomized phase II study of buparlisib (BKM120) or placebo plus paclitaxel in patients ...
WEST LAFAYETTE, Ind. — A Purdue University professor and several international researchers have developed a new method and algorithm that can predict the recurrence of prostate cancer in patients ...
Omitting race and ethnicity from colorectal cancer (CRC) recurrence risk prediction models could decrease their accuracy and fairness, particularly for minority groups, potentially leading to ...
Approximately 20% to 30% of men with prostate cancer experience disease recurrence within 5 years of therapeutic intervention. 1 A key challenge in managing these patients is a scarcity of accurate ...
Researchers have developed a new AI-powered algorithm to help understand how different cells organize themselves into particular tissues and communicate with one another. Researchers from Children's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results